Moderna, Switzerland's Lonza strike deal on potential COVID-19 vaccine

Moderna Inc and Swiss contract drugmaker Lonza Group AG said on Friday they would accelerate the manufacturing of the U.S. drug developer's potential coronavirus vaccine.


from Reuters: Science News https://ift.tt/2yX6R8z

Trump to leave White House on Friday for first time in a month

U.S. President Donald Trump will leave the White House on Friday for the first time in a month when he travels to the Camp David presidential retreat in Maryland.


from Reuters: U.S. https://ift.tt/2WhN8Z5

Tesla cuts price for China-made Model 3 cars by 10% to qualify for subsidies

U.S. electric vehicle maker Tesla Inc said in Friday it has cut the starting price for China-made Model 3 sedans by 10% to qualify for subsidies in the world's biggest auto market.


from Reuters: Technology News https://ift.tt/3aUyIn2

Apple, Huawei boost market share, as first-quarter China smartphone shipments fall: Canalys

Apple Inc and Huawei Technologies [HWT.UL] each captured a higher share of China's smartphone market in the first quarter, according to data from research firm Canalys released on Friday.


from Reuters: Technology News https://ift.tt/2VQDPjW

Half of U.S. states easing coronavirus restrictions as jobless numbers grow

As White House economic reopening guidance expired on Thursday after two weeks in place, half of all U.S. states forged ahead with easing restrictions on restaurants, retail and other businesses in hopes of reviving coronavirus-stricken commerce.


from Reuters: U.S. https://ift.tt/2xox27R

U.S. appeals court rules against Trump attempt to withhold funds from 'sanctuary' cities

A U.S. appeals court on Thursday ruled against a Trump administration attempt to withhold millions of dollars from so-called "sanctuary" jurisdictions that limit cooperation with federal immigration enforcement.


from Reuters: U.S. https://ift.tt/3d5exEE

SoftBank to write down WeWork by $6.6 billion, compounding portfolio misery

SoftBank Group Corp said it sees a loss of around 700 billion yen ($6.6 billion) for the year ended March on the portion of its WeWork investment held outside the Vision Fund, as the virus compounds woes at one of the firm's biggest bets.


from Reuters: Technology News https://ift.tt/3bQdyIb

Nokia makes small profit despite supply disruption

Nokia Oyj on Thursday reported a 2% fall in first-quarter revenue as it took a hit of about 200 million euros ($217 million) to its topline largely because the COVID-19 pandemic disrupted supply from operations in China.


from Reuters: Technology News https://ift.tt/2W7o8ns

California likely to announce closure of state's beaches and parks: local media

California Governor Gavin Newsom is likely to announce on Thursday the closure of the state's beaches and parks after crowds jammed beaches last weekend, according to a memo cited by local media, amid concerns over the coronavirus pandemic.


from Reuters: U.S. https://ift.tt/2WerBjZ

Swisscom warns curbs on antenna upgrade stalling 5G rollout; keeps 2020 outlook

State-controlled telecoms group Swisscom AG said on Thursday that the rollout of its new fifth-generation (5G) mobile technology was getting stalled due to the governments' resistance to installing upgraded antennas.


from Reuters: Technology News https://ift.tt/3cZ4YHe

Proximus says receives temporary 5G license

Proximus, the first mobile operator to launch a 5G network in Belgium, said on Thursday that market regulator BIPT has allotted temporary 5G licences to it and four other companies.


from Reuters: Technology News https://ift.tt/3fasOBV

Telecom operator Orange posts higher sales as France business picks up despite virus

Telecoms operator Orange posted higher revenues for the first quarter on Thursday, as business in its French home market improved despite the onset of the coronavirus crisis that dented its equipment sales.


from Reuters: Technology News https://ift.tt/2Sl5yY6

Fauci says leak concerns fueled his White House revelation of Gilead drug results

Concerns over leaks compelled the top U.S. infectious disease official to reveal data on Gilead Sciences Inc’s experimental drug remdesivir, the first in a scientifically rigorous clincial trial to show benefit in treating COVID-19.


from Reuters: U.S. https://ift.tt/2zJqxNH